These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
639 related items for PubMed ID: 28468003
1. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1. Wang Y, Wang W, Xu H, Sun Y, Sun J, Jiang Y, Yao J, Tian Y. Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003 [Abstract] [Full Text] [Related]
3. Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction. Luo Y, Sun G, Dong X, Wang M, Qin M, Yu Y, Sun X. PLoS One; 2015; 10(3):e0120259. PubMed ID: 25799286 [Abstract] [Full Text] [Related]
5. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1+/- mice display increases atherosclerotic plaque stability. Fang S, Sun S, Cai H, Zou X, Wang S, Hao X, Wan X, Tian J, Li Z, He Z, Huang W, Liang C, Zhang Z, Yang L, Tian J, Yu B, Sun B. Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375 [Abstract] [Full Text] [Related]
8. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway. Wu N, Li RQ, Li L. Biochem Biophys Res Commun; 2018 Jun 22; 501(2):343-350. PubMed ID: 29567472 [Abstract] [Full Text] [Related]
10. Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis. Jiang L, Wang J, Jiang J, Zhang C, Zhao M, Chen Z, Wang N, Hu D, Liu X, Peng H, Lian M. Eur J Pharm Biopharm; 2020 Jan 22; 146():101-110. PubMed ID: 31841689 [Abstract] [Full Text] [Related]
13. Zedoarondiol Attenuates Endothelial Cells Injury Induced by Oxidized Low-Density Lipoprotein via Nrf2 Activation. Mao H, Tao T, Wang X, Liu M, Song D, Liu X, Shi D. Cell Physiol Biochem; 2018 Jan 22; 48(4):1468-1479. PubMed ID: 30064139 [Abstract] [Full Text] [Related]
14. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling. Wang N, Zhang X, Ma Z, Niu J, Ma S, Wenjie W, Chen J. Biomed Pharmacother; 2020 Mar 22; 123():109729. PubMed ID: 31887543 [Abstract] [Full Text] [Related]
15. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Karunakaran D, Geoffrion M, Wei L, Gan W, Richards L, Shangari P, DeKemp EM, Beanlands RA, Perisic L, Maegdefessel L, Hedin U, Sad S, Guo L, Kolodgie FD, Virmani R, Ruddy T, Rayner KJ. Sci Adv; 2016 Jul 22; 2(7):e1600224. PubMed ID: 27532042 [Abstract] [Full Text] [Related]
16. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways. Qin M, Luo Y, Meng XB, Wang M, Wang HW, Song SY, Ye JX, Pan RL, Yao F, Wu P, Sun GB, Sun XB. Vascul Pharmacol; 2015 Jul 22; 70():23-34. PubMed ID: 25849952 [Abstract] [Full Text] [Related]